vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Stitch Fix, Inc. (SFIX). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $342.1M, roughly 1.2× Stitch Fix, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs -1.9%, a 7.1% gap on every dollar of revenue.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

Stitch Fix, Inc. is an online personal styling service in the United States. It uses recommendation algorithms and data science to personalize clothing items based on size, budget and style. The company was founded in 2011 and had an initial public offering in 2017 with a valuation of $1.6 billion. Stitch Fix generated $1.6 billion in net revenue in its fiscal year 2023, a decrease of 21% year-over-year and reported 3,297,000 active clients in September 2023. It is headquartered in San Franci...

GRDN vs SFIX — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.2× larger
GRDN
$397.6M
$342.1M
SFIX
Higher net margin
GRDN
GRDN
7.1% more per $
GRDN
5.3%
-1.9%
SFIX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GRDN
GRDN
SFIX
SFIX
Revenue
$397.6M
$342.1M
Net Profit
$20.9M
$-6.4M
Gross Margin
21.5%
43.6%
Operating Margin
7.7%
-2.5%
Net Margin
5.3%
-1.9%
Revenue YoY
7.3%
Net Profit YoY
-1.7%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
SFIX
SFIX
Q4 25
$397.6M
$342.1M
Q3 25
$377.4M
$311.2M
Q2 25
$344.3M
$325.0M
Q1 25
$329.3M
$312.1M
Q4 24
$318.8M
Q3 24
$314.4M
$319.6M
Q2 24
$322.7M
Q1 24
$330.4M
Net Profit
GRDN
GRDN
SFIX
SFIX
Q4 25
$20.9M
$-6.4M
Q3 25
$9.8M
$-8.6M
Q2 25
$9.0M
$-7.4M
Q1 25
$9.4M
$-6.5M
Q4 24
$-6.3M
Q3 24
$-122.0M
$-36.5M
Q2 24
$-21.3M
Q1 24
$-35.5M
Gross Margin
GRDN
GRDN
SFIX
SFIX
Q4 25
21.5%
43.6%
Q3 25
19.8%
43.6%
Q2 25
19.8%
44.2%
Q1 25
19.5%
44.5%
Q4 24
45.4%
Q3 24
19.4%
44.6%
Q2 24
45.5%
Q1 24
43.4%
Operating Margin
GRDN
GRDN
SFIX
SFIX
Q4 25
7.7%
-2.5%
Q3 25
4.3%
-3.6%
Q2 25
3.7%
-3.0%
Q1 25
3.9%
-2.9%
Q4 24
-2.8%
Q3 24
-33.3%
-13.1%
Q2 24
-7.7%
Q1 24
-11.5%
Net Margin
GRDN
GRDN
SFIX
SFIX
Q4 25
5.3%
-1.9%
Q3 25
2.6%
-2.8%
Q2 25
2.6%
-2.3%
Q1 25
2.9%
-2.1%
Q4 24
-2.0%
Q3 24
-38.8%
-11.4%
Q2 24
-6.6%
Q1 24
-10.8%
EPS (diluted)
GRDN
GRDN
SFIX
SFIX
Q4 25
$-0.05
Q3 25
$-0.06
Q2 25
$-0.06
Q1 25
$-0.05
Q4 24
$-0.05
Q3 24
$-0.29
Q2 24
$-0.18
Q1 24
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
SFIX
SFIX
Cash + ST InvestmentsLiquidity on hand
$65.6M
$244.2M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$217.9M
$204.1M
Total Assets
$412.7M
$530.7M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
SFIX
SFIX
Q4 25
$65.6M
$244.2M
Q3 25
$36.5M
$234.9M
Q2 25
$18.8M
$234.2M
Q1 25
$14.0M
$219.1M
Q4 24
$253.3M
Q3 24
$37.2M
$247.0M
Q2 24
$244.5M
Q1 24
$229.8M
Total Debt
GRDN
GRDN
SFIX
SFIX
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$34.3M
Q2 24
Q1 24
Stockholders' Equity
GRDN
GRDN
SFIX
SFIX
Q4 25
$217.9M
$204.1M
Q3 25
$195.5M
$203.0M
Q2 25
$179.7M
$200.4M
Q1 25
$163.2M
$197.8M
Q4 24
$190.5M
Q3 24
$133.9M
$187.0M
Q2 24
$208.9M
Q1 24
$213.3M
Total Assets
GRDN
GRDN
SFIX
SFIX
Q4 25
$412.7M
$530.7M
Q3 25
$390.0M
$480.6M
Q2 25
$356.3M
$484.7M
Q1 25
$334.0M
$472.6M
Q4 24
$507.1M
Q3 24
$348.0M
$486.9M
Q2 24
$537.0M
Q1 24
$538.3M
Debt / Equity
GRDN
GRDN
SFIX
SFIX
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.26×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
SFIX
SFIX
Operating Cash FlowLast quarter
$34.6M
$10.9M
Free Cash FlowOCF − Capex
$5.6M
FCF MarginFCF / Revenue
1.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$4.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
SFIX
SFIX
Q4 25
$34.6M
$10.9M
Q3 25
$28.2M
$7.0M
Q2 25
$19.9M
$20.5M
Q1 25
$17.6M
$-16.2M
Q4 24
$14.3M
Q3 24
$8.2M
Q2 24
$21.7M
Q1 24
$-22.3M
Free Cash Flow
GRDN
GRDN
SFIX
SFIX
Q4 25
$5.6M
Q3 25
$24.2M
$2.8M
Q2 25
$16.0M
Q1 25
$-19.4M
Q4 24
$9.9M
Q3 24
$4.5M
Q2 24
$18.9M
Q1 24
$-26.1M
FCF Margin
GRDN
GRDN
SFIX
SFIX
Q4 25
1.6%
Q3 25
6.4%
0.9%
Q2 25
4.9%
Q1 25
-6.2%
Q4 24
3.1%
Q3 24
1.4%
Q2 24
5.9%
Q1 24
-7.9%
Capex Intensity
GRDN
GRDN
SFIX
SFIX
Q4 25
1.6%
Q3 25
1.1%
1.4%
Q2 25
1.4%
Q1 25
1.0%
Q4 24
1.4%
Q3 24
1.2%
Q2 24
0.9%
Q1 24
1.1%
Cash Conversion
GRDN
GRDN
SFIX
SFIX
Q4 25
1.65×
Q3 25
2.87×
Q2 25
2.21×
Q1 25
1.86×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons